top.646
( MENAFN - GetNews) "According to a market report by Lucintel, the future of the global 3D printing medical device market looks promising with opportunities in the medical & surgical centers, Pharmaceutical & biotechnology, and academic institutions. The global 3D printing medical device market is expected to reach an estimated $4 billion by 2030 from $2.2 billion in 2023, at a CAGR of 7.0% from 2024 to 2030."According to a market report by Lucintel, the future of the global 3D printing medical device market looks promising with opportunities in the medical & surgical centers, pharmaceutical & biotechnology, and academic institutions. The global 3D printing medical device market is expected to reach an estimated $4 billion by 2030 from $2.2 billion in 2023, at a CAGR of 7.0% from 2024 to 2030. According to a market report by Lucintel, the future of the global 3D printing medical device market looks promising with opportunities in the medical & surgical centers, pharmaceutical & biotechnology, and academic institutions. The global 3D printing medical device market is expected to reach an estimated $4 billion by 2030 from $2.2 billion in 2023, at a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are technological advancements, rising prevalence of osteoarthritis, and increasing public-private funding for 3D printing activities. A more than 150-page report to understand trends, opportunity and forecast in 3D printing medical device market to 2030 by technology (laser beam melting, photo polymerization, electron beam melting, droplet deposition, and three-dimensional printing (3DP)), component (equipment, materials (plastics, ceramics, and metal), software & services, and others), application (surgical guides, surgical instruments, prosthetics and implants, tissue engineering products, and others), end use (medical and surgical centers, pharmaceutical & biotechnology, etc.), and regions. Lucintel forecasts that the photo polymerization technology based 3D printing market is expected to witness the highest growth over the forecast period due to the widespread application of this technology across the medical industry, such as manufacturing surgical guides (orthopedic and dental), prosthetics and implants, porous scaffolds, and dental restorations. Within the 3D printing technology market, equipment, materials, and software & services are major component type. The software & services market is expected to witness the highest growth due to the advent of ongoing technological advancements in software solutions to produce high-quality 3D printed medical products. Download sample by clicking on 3D printing medical device market North America is expected to remain the largest market during the forecast period mainly due to the rapid adoption of this technology, established medical infrastructure, and ongoing R&D activities. APAC is likely to witness the highest growth over the forecast period due to establishment of new 3D printing research, training, and education centers and growing efforts by leading market players for expanding their distribution networks in emerging Asian countries. 3D Systems Corporation, Stratasys, GE Healthcare, Materialise NV, Renishaw are the major suppliers in the 3D printing medical device market. This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at ... To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard. About Lucintel At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. Contact: Roy Almaguer Lucintel Dallas, Texas, USA Email: ... Tel. +1-972-636-5056 Explore Our Latest Publications Volatile Corrosion Inhibitor Market Bleaching Clay Market Clear Brine Fluid Market Flock Adhesive Market Forestry Lubricant Market Endocavity Transducer Market MENAFN19122024003238003268ID1109014534 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.The Drug Regulatory Authority of Pakistan (DRAP) has imposed a ban on the sale and use of a particular batch of Nabaxo 10 mg tablets, citing quality concerns, ARY News reported. According to details, DRAP issued a product recall alert for batch 263 of Nabaxo tablets, manufactured by Wenovo Pharmaceuticals, Taxila. This batch was deemed substandard after failing to meet quality control standards during testing conducted by the Drug Testing Lab, Rawalpindi. The Nabaxo tablet, used for conditions like thrombosis and pulmonary embolism to prevent blood clots in veins and lungs, contains the active ingredient Rivaroxaban. However, the substandard batch raises concerns over treatment efficacy. DRAP directed the manufacturer to halt the supply of the affected batch and recall it from the market. Chemists and distributors have been instructed to stop sales of the batch immediately and return their stock. Meanwhile, doctors and patients are advised to avoid the use of the affected tablets. Regulatory field forces have been tasked with increasing market surveillance to ensure the removal of the defective batch and eradicate counterfeit versions of Nabaxo from circulation. DRAP urged distributors to report any identified stocks from the affected batch promptly. This proactive measure aims to safeguard public health by preventing the circulation of substandard medicine. Read More: DRAP ‘directs’ provinces to launch crack down against illegal drugs On 16 Nov 2024, DRAP issued directives to provincial governments to crack down on illegal drugs and medical devices. As per details, the development came after revelation of imported illegal medicines and surgical instruments being used in hospitals. Sources revealed that DRAP sent letters to all four provinces, Azad Kashmir, and Gilgit-Baltistan, instructing them to take action against those selling, using, or importing unauthorised medical products. The regulatory body had also ordered its field force to conduct effective surveillance of the medicine market and investigate the supply chain of illegal products.
ECB chief urges more EU integration as threats grow
The commodities sector traded softer during the first week of December—a month that traditionally sees activity slow to a halt ahead of the holiday season and year-end. During this period, traders and investors typically focus on defending hard-earned gains while minimising losses, potentially leaving markets directionless as they prepare for 2025—a year expected to bring both significant risks and opportunities. The Bloomberg Commodity Total Return Index, which tracks a basket of 24 major futures markets spanning energy, metals, and agricultural commodities, slipped by 0.7% during the week, reducing its year-to-date return to 3.6%. Gains across the industrial metal, grains and soft sectors being offset by a near 4% setback in energy, courtesy of a near 10% slump in natural gas and distillate (diesel) weakness. On an individual level the top performing commodities were cocoa, wheat, copper and silver, while the weakness as mentioned was being led by natural gas, diesel, platinum and gold. Weekly performance table The main event of the week in commodities was the OPEC+ meeting, and following two postponements, the group delayed further to mitigate the risk of price weakness amid the release of currently unwanted barrels. This decision was underpinned by concerns about robust production from non-OPEC+ producers next year, potentially leading to a major crude surplus and, from OPEC’s perspective, undesirable price weakness. In the short term, the combination of US tariff threats, elevated OPEC spare capacity and rising production elsewhere—not least in the US, where output has reached a record 13.5 million barrels per day—has reduced the likelihood of an upside price movement. Nonetheless, some upside risks remain. These include the Trump administration potentially adding fresh sanctions on Iran and Venezuela, as well as geopolitical risks stemming from the Russia–Ukraine war and the Middle East conflict. A proposal by Treasury Secretary nominee Scott Bessent to increase US production by 3 million barrels of oil equivalent through 2028 will likely centre on increased natural gas and natural gas liquids production. With WTI trading below USD 70, however, incentives for further production increases remain constrained. Brent and WTI crude oil futures have traded sideways over the past two years as OPEC successfully managed to reduce volatility while supporting prices during a period of softening demand in China. Brent support, as indicated in the chart, is found near USD 70 per barrel, followed by USD 65 per barrel, while the downtrend from 2022 currently provides resistance near USD 80 per barrel. Brent Crude – Source: Saxo The industrial metals sector was heading for its third consecutive weekly gain as it continued to claw back losses resulting from proposed US tariffs on imports, particularly from China—a move that could disrupt global trade and reduce demand for industrial metals. Copper, which dropped over 5% last month due to additional pressure from concerns about a potential slowdown in the energy transition, witnessed its best week since September. It moved solidly higher and away from recently challenged key support levels. Prices were supported by a continued decline in exchange-monitored warehouse stocks to a May low, particularly in China, and by investor optimism about measures to bolster China’s flagging economy being approved at a key meeting in Beijing next week. Despite the mentioned challenges next year, the global shift toward electrification continues, particularly in China, where the EV and hybrid boom increasingly signals a sooner-than-expected slowdown in demand for traditional fuels. In the US, the surge in power demand from data centres and AI technologies is reshaping the energy landscape. After two decades of flat electricity demand, the US Energy Information Administration (EIA) projects consistent annual increases through 2050, driven largely by these energy-intensive industries. This growth is expected to boost not only natural gas demand but also the need for industrial metals like copper, which is critical for conducting increased electrical loads. High Grade Copper – Source: Saxo High-grade copper, in an uptrend since the 2020 low, approached support last month near USD 4.00 per pound before rebounding on renewed demand from China and the energy transition. For now, and until China provides further support, the price is likely to remain capped below USD 4.35 per pound. Silver’s 55% exposure to industrial uses saw the grey metal enjoy the tailwind from firmer industrial metal prices, leading to an outperformance against rangebound gold—its precious metal peer—which suffered a small weekly loss but remains well supported into 2025. Expectations for persistent global uncertainties are driving demand for gold as a safe-haven asset, supported by lower interest rates and continued central bank demand. While we believe gold will resume its ascent next year toward a fresh record high of around USD 3,000 an ounce, silver appears poised for even better performance due to a sizeable market deficit in 2025, driven by continued demand growth in electronics, particularly photovoltaics. Spot Silver – Source: Saxo Following a relative deep October to November correction, silver buyers returned after support was re-established at USD 29.65, the 0.618 correction of the September to November rally and now a twice rejected level. For now resistance at USD 31.65 has yet to be challenged and broken in order to achieve an even greater comeback. Other commodities performing well included cocoa, which returned to trade USD 10,000 per tonne, having started the year around USD 4,000 per tonne amid the prospect of a multiyear structural supply-demand deficit due to much weaker production in Ivory Coast and Ghana—two producers responsible for more than half the world’s production. Analysts expect the 2024/25 season to yield another deficit at a time when global stocks are already depleted. Meanwhile, Arabica coffee futures resumed their run higher following a sharp correction after prices recently reached but failed to break above the 1977 high at USD 3.3750. Coffee prices remain supported by a tightening supply outlook in Brazil, the world’s top producer of Arabica, and Vietnam, the main producer of the Robusta bean. A recent decline in wheat futures in Chicago and Paris, driven by the prospect of ample supplies, was arrested as the dollar softened and poor winter wheat crop conditions in Russia, combined with excessive rains in Australia—two major suppliers of the grain—lifted hopes for US and European export demand. The agricultural sector has experienced a very mixed year, with strong gains in cocoa, coffee, and orange juice due to the concentration of production in regions negatively impacted by adverse weather, partly offset by losses across key crops amid ample supply following another bumper production year globally. Source: Saxo BankAP Business SummaryBrief at 4:31 p.m. EST
Farage: Badenoch must apologise for ‘crazy conspiracy theory’ on Reform numbers
Andrew Luck returns to Stanford as the GM of the football programNinth American telecoms firm hit by a massive espionage campaign that gave Chinese officials access to private texts, phone calls
WASHINGTON (AP) — said he can't guarantee that his on key U.S. foreign trade partners won't for American consumers and he suggested once more that some who pursued legal cases against him should be imprisoned. The president-elect, in a wide-ranging interview with NBC's “Meet the Press” that aired Sunday, also touched on monetary policy, immigration, abortion and health care, and U.S. involvement in Ukraine, Israel and elsewhere. Trump often mixed declarative statements with caveats, at one point cautioning “things do change.” A look at some of the issues covered: Trump has threatened broad trade penalties, but said he didn’t believe that added costs on those imported goods for American companies would lead to higher prices for U.S. consumers. He stopped short of a pledge that U.S. households won't be paying more as they shop. “I can’t guarantee anything. I can’t guarantee tomorrow,” Trump said, seeming to open the door to accepting the reality of how import levies typically work as goods reach the retail market. That's a different approach from Trump's typical speeches throughout the 2024 campaign, when he framed his election as a sure way to curb inflation. In the interview, Trump defended tariffs generally, saying they are "going to make us rich.” He has pledged that, on his first day in office in January, he would impose 25% tariffs on all goods imported from Mexico and Canada unless those countries satisfactorily stop illegal immigration and the flow of illegal drugs such as fentanyl into the United States. He also has threatened additional tariffs on China to help force that country to crack down on fentanyl production. ”All I want to do is I want to have a level, fast, but fair playing field,” Trump said. He offered conflicting statements on how he would approach the justice system after winning election despite being convicted of 34 felonies in a New York state court and being indicted in other cases for his handling of national security secrets and efforts to overturn his 2020 loss to Democrat Joe Biden. “Honestly, they should go to jail,” Trump said of members of Congress who investigated the Capitol riot by his supporters who wanted him to remain in power. The president-elect underscored his contention that he can use the justice system against others, including special prosecutor Jack Smith, who led the case on Trump’s role in the siege on Jan. 6, 2021. Trump confirmed his plan to pardon supporters who were convicted for their roles in the riot, saying he would take that action on his first day in office. As for the idea of revenge driving potential prosecutions, Trump said: “I have the absolute right. I’m the chief law enforcement officer, you do know that. I’m the president. But I’m not interested in that." At the same time, Trump singled out lawmakers on a special House committee who had investigated the insurrection, citing Rep. Bennie Thompson, D-Miss., and former Rep. Liz Cheney, R-Wyo. “Cheney was behind it ... so was Bennie Thompson and everybody on that committee,” Trump said. Asked specifically whether he would direct his administration to pursue cases, he said, “No,” and suggested he did not expect the FBI to quickly undertake investigations into his political enemies. But at another point, Trump said he would leave the matter up to Pam Bondi, his pick as attorney general. “I want her to do what she wants to do,” he said. Such threats, regardless of Trump's inconsistencies, have been taken seriously enough by many top Democrats that Biden is considering issuing blanket, to protect key members of his outgoing administration. Trump did seemingly back off his campaign rhetoric calling for Biden to be investigated, saying, “I’m not looking to go back into the past.” Trump repeatedly mentioned his promises to seal the U.S.-Mexico border and deport millions of people who are in the U.S. illegally through a mass deportation program. “I think you have to do it,” he said. He suggested he would try to use executive action to end “birthright” citizenship under which people born in the U.S. are considered citizens — although such protections are spelled out in the Constitution. Asked specifically about the future for people who were brought into the country illegally as children and have been shielded from deportation in recent years, Trump said, “I want to work something out,” indicating he might seek a solution with Congress. But Trump also said he does not “want to be breaking up families” of mixed legal status, “so the only way you don’t break up the family is you keep them together and you have to send them all back.” Long a members for not spending more on their own defense, Trump said he “absolutely” would remain in the alliance “if they pay their bills.” Pressed on whether he would withdraw if he were dissatisfied with allies’ commitments, Trump said he wants the U.S. treated “fairly” on trade and defense. He waffled on a NATO priority of containing Russia and President Vladimir Putin. Trump suggested Ukraine should prepare for less U.S. aid in its defense against Putin’s invasion. “Possibly. Yeah, probably. Sure,” Trump said of reducing Ukraine assistance from Washington. Separately, Trump has . Asked about Putin, Trump said initially that he has not talked to the Russian leader since Election Day last month, but then hedged: “I haven’t spoken to him recently.” Trump said when pressed, adding that he did not want to “impede the negotiation.” The president-elect said he has no intention, at least for now, of asking Federal Reserve Chairman Jerome Powell to step down before Powell's term ends in 2028. Trump said during the campaign that presidents should have , including interest rates. Trump did not offer any job assurances for FBI Director Christopher Wray, whose term is to end in 2027. Asked about Wray, Trump said: “Well, I mean, it would sort of seem pretty obvious” that if the Senate confirms Kash Patel as his then “he’s going to be taking somebody’s place, right? Somebody is the man that you’re talking about.” Trump promised that the government efficiency effort led by Elon Musk and Vivek Ramaswamy will not threaten Social Security. “We're not touching Social Security, other than we make it more efficient,” he said. He added that “we're not raising ages or any of that stuff.” He was not so specific about abortion or his long-promised overhaul of the Affordable Care Act. On abortion, Trump continued and said he would “probably” not move to restrict access to the abortion pills that now account for a majority of pregnancy terminations, according to the Guttmacher Institute, which supports abortion rights. But pressed on whether he would commit to that position, Trump replied, “Well, I commit. I mean, are -- things do -- things change. I think they change.” Reprising a line from his against Vice President Kamala Harris, Trump again said he had “concepts” of a plan to substitute for the 2010 Affordable Care Act, which he called “lousy health care.” He added a promise that any Trump version would maintain insurance protections for Americans with preexisting health conditions. He did not explain how such a design would be different from the status quo or how he could deliver on his desire for “better health care for less money.” Barrow reported from Atlanta. Associated Press writers Adriana Gomez Licon in Fort Lauderdale, Florida, and Jill Colvin and Michelle L. Price in New York contributed to this report.What is a insect breeding tray? Its Features and Applications
Percentages: FG 39.726, FT .588. 3-Point Goals: 9-21, .429 (Lacey 3-6, McMiller 3-5, Petticord 2-6, Thompson 1-3, Perkins 0-1) Blocked Shots: 3 (Adams 1, McMiller 1, Perkins 1) Turnovers: 9 (McMiller 4, Thompson 2, Lacey 1, Perkins 1, Walker 1) Steals: 8 (Adams 6, Lacey 1, McMiller 1) Technical Fouls: None Percentages: FG 39.394, FT .667. 3-Point Goals: 4-21, .190 (Mays-Prince 3-5, Jackson 1-6, Gaines 0-1, Gwynn 0-3, Akinsola 0-1, Eddings 0-5) Blocked Shots: 5 (Johnson 2, Jackson 1, Green 1, Akinsola 1) Turnovers: 16 (Gaines 4, Gwynn 4, Mays-Prince 3, Jackson 2, Johnson 1, Green 1, Akinsola 1) Steals: 5 (Gwynn 2, Eddings 2, Green 1) Technical Fouls: None A_0 Officials_Erika Herriman, Kenya Kirkland, Angelica Suffren
‘Magnificent’: Frosty Mango unveils new soft-serve ice-creamsThe Reform UK leader pushed back against reports suggesting that legal action would be the next step, saying he would make a decision in the next couple of days about his response if there is no apology for the “crazy conspiracy theory”. Mr Farage also said the party has “opened up our systems” to media outlets, including The Daily Telegraph and The Financial Times, in the interests of “full transparency to verify that our numbers are correct”. His remarks came after Conservative Party leader Kemi Badenoch accused Mr Farage of “fakery” in response to Reform claiming they had surpassed the Tories in signed-up members. Mrs Badenoch said Reform’s counter was “coded to tick up automatically”. A digital counter on the Reform website showed a membership tally before lunchtime on Boxing Day ticking past the 131,680 figure declared by the Conservative Party during its leadership election earlier this year. Mr Farage, on whether he was threatening legal action or not, told the PA news agency: “I haven’t threatened anything. I’ve just said that unless I get an apology, I will take some action. “I haven’t said whether it’s legal or anything.” He added: “All I’ve said is I want an apology. If I don’t get an apology, I will take action. “I will decide in the next couple of days what that is. So I’ve not specified what it is.” Mr Farage, on the move to make membership data available to media organisations, said: “We feel our arguments are fully validated. “She (Mrs Badenoch) has put out this crazy conspiracy theory and she needs to apologise.” The accusations of fraud and dishonesty made against me yesterday were disgraceful. Today we opened up our systems to The Telegraph, Spectator, Sky News & FT in the interests of full transparency to verify that our data is correct. I am now demanding @KemiBadenoch apologises. — Nigel Farage MP (@Nigel_Farage) December 27, 2024 On why Mrs Badenoch had reacted as she did, Mr Farage said: “I would imagine she was at home without anybody advising her and was just angry.” Mr Farage, in a statement issued on social media site X, also said: “The accusations of fraud and dishonesty made against me yesterday were disgraceful. “Today we opened up our systems to The Telegraph, Spectator, Sky News and FT in the interests of full transparency to verify that our data is correct. “I am now demanding Kemi Badenoch apologises.” A Conservative Party source claimed Mr Farage was “rattled” that his Boxing Day “publicity stunt is facing serious questions”. They added: “Like most normal people around the UK, Kemi is enjoying Christmas with her family and looking forward to taking on the challenges of renewing the Conservative Party in the New Year.” Mrs Badenoch, in a series of messages posted on X on Thursday, said: “Farage doesn’t understand the digital age. This kind of fakery gets found out pretty quickly, although not before many are fooled.” There were 131,680 Conservative members eligible to vote during the party’s leadership election to replace Rishi Sunak in the autumn. Mrs Badenoch claimed in her thread that “the Conservative Party has gained thousands of new members since the leadership election”. Elsewhere, Mr Farage described Elon Musk as a “bloody hero” and said he believes the US billionaire can help attract younger voters to Reform. Tech entrepreneur Mr Musk met Mr Farage earlier this month at Donald Trump’s Mar-a-Lago resort in Florida, amid rumours of a possible donation to either Mr Farage or Reform. Mr Farage told The Daily Telegraph newspaper: “The shades, the bomber jacket, the whole vibe. Elon makes us cool – Elon is a huge help to us with the young generation, and that will be the case going on and, frankly, that’s only just starting. “Reform only wins the next election if it gets the youth vote. The youth vote is the key. Of course, you need voters of all ages, but if you get a wave of youth enthusiasm you can change everything. “And I think we’re beginning to get into that zone – we were anyway, but Elon makes the whole task much, much easier. And the idea that politics can be cool, politics can be fun, politics can be real – Elon helps us with that mission enormously.”
The Drug Regulatory Authority of Pakistan (DRAP) has imposed a ban on the sale and use of a particular batch of Nabaxo 10 mg tablets, citing quality concerns, ARY News reported. According to details, DRAP issued a product recall alert for batch 263 of Nabaxo tablets, manufactured by Wenovo Pharmaceuticals, Taxila. This batch was deemed substandard after failing to meet quality control standards during testing conducted by the Drug Testing Lab, Rawalpindi. The Nabaxo tablet, used for conditions like thrombosis and pulmonary embolism to prevent blood clots in veins and lungs, contains the active ingredient Rivaroxaban. However, the substandard batch raises concerns over treatment efficacy. DRAP directed the manufacturer to halt the supply of the affected batch and recall it from the market. Chemists and distributors have been instructed to stop sales of the batch immediately and return their stock. Meanwhile, doctors and patients are advised to avoid the use of the affected tablets. Regulatory field forces have been tasked with increasing market surveillance to ensure the removal of the defective batch and eradicate counterfeit versions of Nabaxo from circulation. DRAP urged distributors to report any identified stocks from the affected batch promptly. This proactive measure aims to safeguard public health by preventing the circulation of substandard medicine. Read More: DRAP ‘directs’ provinces to launch crack down against illegal drugs On 16 Nov 2024, DRAP issued directives to provincial governments to crack down on illegal drugs and medical devices. As per details, the development came after revelation of imported illegal medicines and surgical instruments being used in hospitals. Sources revealed that DRAP sent letters to all four provinces, Azad Kashmir, and Gilgit-Baltistan, instructing them to take action against those selling, using, or importing unauthorised medical products. The regulatory body had also ordered its field force to conduct effective surveillance of the medicine market and investigate the supply chain of illegal products.How to Watch Top 25 Women’s College Basketball Games – Sunday, December 1
Major US indices close mixed. Dow lower for 7th day in a row. S&P unchanged. Nasdaq higher Pres.elect Trump is out to end the daylight saving time US prepares new AI chip restrictions to other countries to box out China - report S&P affirms Mexico's credit ratings Looking at long-dated bonds... European equity close: A finish on the lows of the week MUFG trade of the week: We stay long USD/CAD US Treasury yields have risen every day this week Disappointment sets into the China trade once again France names a new Prime Minister who will look to mend fences China central bank surveys banks on bond buying - report US import prices for November MoM 0.1% vs -0.2% estimate. YoY 1.3% Cananda October manufacturing sales +2.1% vs +1.3% expected Canada October wholesale sales +1.0% vs +0.5% expected ForexLive European FX news wrap: Mixed markets in final stretch of the week ECB's Centeno: The rate cut decision yesterday was fortunately absolutely consensual BOJ reportedly considers skipping rate hike at next week's policy meeting ECB's Makhlouf: The direction of travel on interest rates is clear ECB's Vasle: Declining services inflation strengthened the confidence in return to target Markets: Gold fell -$31.91 or -1.19% at $2648.66. Gold is ending the week up $16.27 or 0.619% WTI crude oil rose $1.07 or 1.3% at $71.10. Crude oil is up $3.88 or 5.77% US yields rose every day this week as the market adjusted to a less accommodative Fed in 2025 as a result of a solid economy. The gains came despite the expectations that the Fed will cut rates by 25 basis points when they need next week. 2 year yield 4.2448% up 5.9 bps. For the week, yields are up 13.7 bps US 10-year yields 4.394%, up 7.1 bps For the week yields are up 25 bps The US stock indices were mixed today with the Dow falling for the 7th day in a row. The S&P was unchanged and the Nasdaq marginally higher Dow industrial average fell -86.06 points or -0.20% at 43828.06. The NASDAQ closed lower for the 7th consecutive day (down 2.82%). For the trading week, the index fell -1.82% S&P index fell -0.16 points or -0.0% at 6051.09. For the trading week the index fell -0.64%. NASDAQ index rose 23.88 points or 0.12% at 19926.72. For the trading week the index squeaked out a small 0.34% gain. In the forex, the USD is closing mixed vs. the major currencies. The USD: -0.32% vs the EUR +0.66% vs the JPY +0.41% vs the GBP +0.07% vs the CHF +0.10% vs the CAD +0.16% vs the AUD +0.16% vs the NZD For the trading week, the USD rose vs all the major currencies as the expectations for the Fed to cut rates in 2025 eased and other central banks cut rates willingly. The SNB cut rates by 50 bps as did the CAD. The ECB cut rates by 25 bps but did talk about 50. The Bank of Japan may not raise rates at their next meeting which is bearish for that currency. The % changes of USD vs the major currencies shows. +0.61% vs EUR +2.42% vs JPY +0.89% vs GBP +1.65% vs CHF +0.61% vs CAD +0.45% vs AUD +1.06% vs NZD .For a review of the technical's driving the major currency pairs CLICK HERE . Key events next week will be highlighted by The Fed meeting and rate decision on Wednesday at 2 PM with the expectations of a 25 bp cut. The Bank of Japan on Thursday with no change expected The BOE will also meet on Thursday with no change expected. IN other key data releases: PMI flash data will be released in Europe and the UK, and then the US on Monday. UK employment data will be released on Tuesday at 2 AM ET Canada CPI data will be released on Tuesday at 8:30 AM ET US retail sales will also be released at 8:30 AM ET (0.6% estimate). UK CPI will be released at 2 AM on Wednesday New Zealand GDP for the quarter will be released on Thursday US final GDP for the third quarter will be released on Thursday at 8:30 AM ET along with the weekly initial jobless claims data. UK retail sales will be released on Friday at 2 AM ET Canada retail sales will be released at 8:30 AM on Friday US PCE data will be released at 8:30 AM on FridayThe Los Angeles Chargers activated running back J.K. Dobbins from injured reserve on Friday. Dobbins is formally listed as questionable but figures to be the team's top running threat for Saturday's road game against the New England Patriots. Teammate Gus Edwards (ankle) was ruled out Thursday. Dobbins has missed the past four games since sustaining a knee injury against the Baltimore Ravens on Nov. 25. He was a full practice participant Thursday before receiving the questionable label. The injury-prone Dobbins was enjoying a solid season prior to the knee ailment, with 766 yards and eight touchdowns on the ground and 28 receptions for 134 yards in 11 games. His career high for rushing yardage is 805 for the Ravens in 2020. Dobbins' return comes with the Chargers (9-6) just one win from clinching an AFC wild-card playoff spot. Los Angeles also elevated safeties Eddie Jackson and Kendall Williamson from the practice squad. --Field Level MediaCanada's Trudeau returns home after Trump meeting without assurances that tariffs are off the table( MENAFN - GetNews) DelveInsight's“ Nontuberculous Mycobacterial Infections market Insights, Epidemiology, and Market Forecast–2034 ” report delivers an in-depth understanding of NTM Infections, historical and forecasted epidemiology, as well as the NTM Infections market trends in the United States. Explore the intricate details of the Nontuberculous Mycobacterial Infections Market: Uncover drug uptake, treatment dynamics, and epidemiological trends with our comprehensive Nontuberculous Mycobacterial Infections Market Forecast. Click here to stay ahead in healthcare innovation @ Nontuberculous Mycobacterial Infections Market Size Key Takeaways from the Non-Tuberculous Mycobacterial Infections Market Report Navigate the complexities of the Nontuberculous Mycobacterial Infections Market: gain insights into drug trends, treatment scenarios, and epidemiological data through our insightful Nontuberculous Mycobacterial Infections Market Forecast. Click here to get more insights @ Nontuberculous Mycobacterial Infections Treatment Market Non-Tuberculous Mycobacterial Infections Epidemiology Segmentation in the 7MM Download the report to understand which factors are driving Non-Tuberculous Mycobacterial Infections epidemiology trends @ Non-Tuberculous Mycobacterial Infections Prevalence Nontuberculous Mycobacterial Infections Marketed Drugs ARIKAYCE is the first FDA-approved therapy indicated for the treatment of MAC lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. ARIKAYCE is a novel, inhaled, once-daily formulation of amikacin, an established antibiotic historically administered intravenously and associated with severe toxicity to hearing, balance, and kidney function. Insmed's proprietary PULMOVANCE liposomal technology enables the delivery of amikacin directly to the lungs, where lung macrophages take it up, targeting the site of infection. This approach prolongs the release of amikacin in the lungs while limiting systemic exposure. ARIKAYCE is administered once daily using the Lamira Nebulizer System manufactured by PARI Pharma GmbH. Nontuberculous Mycobacterial Infections Emerging Drugs Epetraborole (EBO), developed by AN2 Therapeutics, is a novel, once-daily, orally administered investigational treatment for patients with chronic NTM lung disease. Epetraborole is a boron-containing small molecule inhibitor of bacterial leucyl-tRNA synthetase, or LeuRS, an enzyme that catalyzes the attachment of leucine to transfer RNA, or tRNA, molecules, an essential step in protein synthesis. Epetraborole forms a complex with a tRNALEU molecule, trapping the terminal ribonucleotide of tRNALEU in the editing site of the enzyme, which prevents the synthetic site from attaching leucine to tRNALEU thus shutting down tRNA leucylation and leading to a block in protein synthesis. Currently, the drug is in Phase II/III of clinical development for the treatment of patients with NTM lung disease. AN2 Therapeutics intends to expand the indication targeted by epetraborole by pursuing development in other mycobacterial diseases, including treatment-naïve MAC lung disease. AN2 Therapeutics also intends to conduct trials in which they plan to incorporate epetraborole as part of first-line combination treatment for treatment-naive patients with NTM lung disease and M. abscessus lung infections. MNKD-101, a nebulized formulation of clofazimine, is being developed for the treatment of severe chronic and recurrent pulmonary infections, including NTM lung disease. An orally inhaled formulation of clofazimine is anticipated to offer several clinical advantages over the current solid oral dosage form of this drug. MNKD-101 has been designated as both an orphan drug and a qualified infectious disease product by the US FDA for the treatment of pulmonary NTM infections. Mannkind is also assessing the feasibility of developing a dry-powder formulation of clofazimine using Mannkind's technosphere formulation technology. MNKD-101 is designated with fast-track designation by the US FDA for the treatment of NTM lung infections. Mannkind intends to commence a Phase III registration study of MNKD-101 in the US in the second quarter of 2024. SPR720, developed by Spero Therapeutics, is a broad-spectrum oral antibiotic designed to treat NTM pulmonary disease. SPR720 employs a novel mechanism and has no known cross-resistance with marketed antibiotics. SPR720 has demonstrated a broad spectrum of activity in preclinical studies against the most common organisms causing NTM infections, including M. avium complex, or MAC, M. kansasii, and M. abscessus. SPR720 is applicable to both nonrefractory and refractory patients. Unlock insights into the Nontuberculous Mycobacterial Infections Market: discover drug uptake patterns, treatment landscapes, and epidemiological insights with our exclusive Nontuberculous Mycobacterial Infections Market Forecast. Click here @ Nontuberculous Mycobacterial Infections Market Drivers and Barriers Non- Tuberculous Mycobacterial Infections Therapies and Companies Scope of the Non- Tuberculous Mycobacterial Infections Market Report Gain a strategic edge in the Nontuberculous Mycobacterial Infections Market: explore comprehensive drug insights, treatment updates, and epidemiological forecasts in our in-depth Nontuberculous Mycobacterial Infections Market Forecast. Click here to lead in advancements @ Nontuberculous Mycobacterial Infections Clinical Trials Assessment Table of Contents 1. Non- Tuberculous Mycobacterial Infections Market Report Introduction 2. Executive Summary for Non- Tuberculous Mycobacterial Infections 3. SWOT analysis of Non- Tuberculous Mycobacterial Infections 4. Non- Tuberculous Mycobacterial Infections Patient Share (%) Overview at a Glance 5. Non- Tuberculous Mycobacterial Infections Market Overview at a Glance 6. Non- Tuberculous Mycobacterial Infections Disease Background and Overview 7. Non- Tuberculous Mycobacterial Infections Epidemiology and Patient Population 8. Country-Specific Patient Population of Non- Tuberculous Mycobacterial Infections 9. Non- Tuberculous Mycobacterial Infections Current Treatment and Medical Practices 10. Non- Tuberculous Mycobacterial Infections Unmet Needs 11. Non- Tuberculous Mycobacterial Infections Emerging Therapies 12. Non- Tuberculous Mycobacterial Infections Market Outlook 13. Country-Wise Non- Tuberculous Mycobacterial Infections Market Analysis (2020–2034) 14. Non- Tuberculous Mycobacterial Infections Market Access and Reimbursement of Therapies 15. Non- Tuberculous Mycobacterial Infections Market Drivers 16. Non- Tuberculous Mycobacterial Infections Market Barriers 17. Non- Tuberculous Mycobacterial Infections Appendix 18. Non- Tuberculous Mycobacterial Infections Report Methodology 19. DelveInsight Capabilities 20. Disclaimer 21. About DelveInsight About Us DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve. MENAFN19122024003238003268ID1109014527 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Right Time Group Names Jason Moore as Chief Financial OfficerAP News Summary at 6:20 p.m. EST
Week 12 has started with an upset. The Cleveland Browns prevailed over the Pittsburgh Steelers 24-19 on Thursday Night Football , surviving the elements of the first snow game of the 2024 season. Cleveland took a commanding 18-6 lead early in the fourth quarter with Pittsburgh unable to find offensive rhythm, but it came back to seize a 19-18 lead late on fueled by forcing turnovers in the weather. However, Jameis Winston responded with a late nine-play, 45-yard drive to give Cleveland the advantage again. Russell Wilson had the chance to reply one last time for the win, but the Browns swatted down his last-ditch Hail Mary attempt. The shock result moves Cleveland to 3-8, while Pittsburgh dropped to 8-3 in an AFC that is tight at the top. Let's analyze the game further with winners and losers: Chubb has been far from his best after returning from gruesome leg injuries sustained last season, but he played a pivotal role for Cleveland. The 28-year-old rushed for 59 yards on 20 carries for two touchdowns, including the eventual game winner. It was his first multi-rushing touchdown game since Halloween of 2022. Though this game may not spur Cleveland up the AFC ladder, it's a positive sign for Chubb to pick up individual momentum. The Steelers typically deploy a robust defense under Mike Tomlin, but the offensive talent around Wilson has been in question. Mike Williams was acquired at the deadline, but he's still yet to produce for any team this season and did not feature in this game. Wilson completed 21 of 28 passes for 270 yards, one touchdown and a pick, but the offense's inability to consistently move the chains in the first three quarters was evident. Pittsburgh's downfall in this game may have just foreshadowed how its season could end against stronger teams. Cleveland hosted the first snow game of the season. While the temperature and field was just fine during the first half, the snow kicked it up a notch in the second. It predictably resulted in more drops by receivers and fumbles. The two teams combined for five fumbles, with three recovered by the opposition. Cleveland's fourth-quarter miscue could've been costly, but it held on for the victory. Most of the key team stats point to this being a game the Steelers let slip away. Specifically, the third-down disparity ended on a brutal note from Pittsburgh's point of view. Pittsburgh converted on a solid 7-for-16 third downs, and had more total yards, drives and possession time along with fewer penalties. Cleveland, on the other hand, converted on just 1-for-10 third downs. But it flipped the switch when it mattered the most, moving the chain on all four fourth-down attempts. Pittsburgh wasn't limited by the snow given how it managed to retake the lead during the pouring, but the statistics will definitely frustrate Mike Tomlin and Co. After a slow and poor first eight weeks of the season, Jeudy has found improved form with Winston as QB1. He ended the game with six catches on six targets for 85 yards, coming up big whenever the Browns needed him. It also marked four straight games of at least five or more catches for the 25-year-old. While that might not sound like a lot for the former first rounder, he logged three straight games of just one catch each from Weeks 5-7. Last time out against the Saints he recorded six catches on 11 targets for a season-high 142 yards and a score.Taurus – (20th April to 20th May) Daily Horoscope Prediction says, Risks make you powerful Look for happy moments with the lover and consider performing the best at work. Expect minor troubles from seniors. Prosperity will be at your side today. Diligent handling of romantic affairs is the need of the hour. Minor issues will be there at the workplace but nothing will stop you from performing brilliantly. Do not invest money blindly and instead go for professional help in financial handling. Health is good. Taurus Love Horoscope Today Do not let egos impact the relationship. Devote more time for the partner and during the conversations, avoid delving into the unpleasant past. Your parents may be supportive today and some females may also take a call on marriage. Single females will be the point of attraction at events or functions and can expect a proposal. Some married lives will see the interference of a third person which may cause turbulence. Some natives will see the partners getting highly emotional and you need to handle this as per the need. Taurus Career Horoscope Today Keep tremors at the office aside and focus on the tasks assigned. Your commitment is crucial as some tasks may also require you to work additional hours. Some clients will not be happy with performance and you will need to pull up the socks to accomplish every assigned task. Those who have interviews lined up can confidently attend them to receive an offer letter. Marketing and salespersons will struggle to convince clients. Taurus Money Horoscope Today Wealth will be your companion today. A previous investment would bring in a good income which will reflect in the lifestyle. You may utilize the money to buy electronic appliances and even a vehicle. The second part of the day is good to seriously consider real estate. Ensure you have proper guidance while trying your fortune in stock, trade, and speculative business. Businessmen will succeed in raising funds through promoters. Taurus Health Horoscope Today Do not let the lifestyle impact your health. Make a balance between the personal and professional life. Start the day with exercise and keep oil and fat off the plate. Some children will develop viral fever, sore throat, or digestion issues today. Female natives may also develop migraine or severe headaches in the second half of the day. Taurus Sign Attributes Strength - Passionate, Practical, Meticulous, Patient, Artsy, Compassionate Weakness Intolerant, Reliant, stubborn Symbol Bull Element Earth Body Part Neck & Throat Sign Ruler Venus Lucky Day Friday Lucky Color Pink Lucky Number 6 Lucky Stone Opal Taurus Sign Compatibility Chart Natural affinity: Cancer, Virgo, Capricorn, Pisces Good compatibility: Taurus, Scorpio Fair compatibility: Aries, Gemini, Libra, Sagittarius Less compatibility: Leo, Aquarius By: Dr. J. N. Pandey Vedic Astrology & Vastu Expert Website: www.astrologerjnpandey.com E-mail: djnpandey@gmail.com Phone: 91-9811107060 (WhatsApp Only)
Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission from purchases made through links on this page. Zoom is to get-togethers as e-gift cards are to meticulously wrapped presents beneath the tree. Just because we didn’t schlep through a mall or play it fast-and-loose with mail delivery services, doesn’t mean we don’t love. If you left your holiday shopping to the last minute, a digital gift is an easy way to save the day. Show your family, friends, co-workers, neighbours, hairdresser, mail-delivery person (though that could be seen as sarcastic), or anyone you have in your email contact list, some love this year with an e-gift card or digital gift. All stores below offer e-gift cards that only require your recipient’s email address. The list provides stores that are perfectly broad and yet acutely personalized, so you give your giftee thoughtful options even at the very last minute. Give the gift of a Disney+ subscription this holiday season. One year of Disney+ Premium rings in at $159.99, and includes access to movies, TV shows and exclusive entertainment (though it can only be used to start a new subscription, not pay for an existing Disney+ account). This streaming platform is more than just entertainment, it’s educational. Learn from the greats as they share how they mastered their field of expertise. Experts include Martha Stewart, Mindy Kaling, Neil Degrasse Tyson, Martin Scorsese and more. A Netflix gift can be purchased through PayPal , and shared directly to the recipient’s email address. The gift card can then be added onto an existing account or used to create a new one. Team Rubicon is a brilliant charity. The concept of this charity is the epitome of win-win. Team Rubicon recruits, trains, equips, organizes and deploys veterans to aid in disaster relief. Not only are veterans uniquely qualified to support communities facing natural disasters, but it re-enrolls veterans in a community with a purpose. Team Rubicon started in 2010 as a response to the Haiti earthquake. Team Rubicon Canada started in 2016 to support one of Canada’s biggest natural disasters in history, the Fort McMurray wildfires. Read more about Team Rubicon here and donate here . This year has been a blunt reminder that we live in a global village, to reference Canadian philosopher Marshall McLuhan. The world worked together to develop a vaccine in historical timing. This year could be the perfect year to Sponsor a Child through World Vision . Canada and World Vision do great work together, check out the current initiative, New Canadian gender equality solution for global hunger . Fashionable friends and family will be sure to appreciate a gift card to Vancouver’s own Aritzia. The brand has tons of cute winter gear to keep warm throughout the season, along with everyday essentials for the office or lounging. A practical gift that’s sure to be used up quickly. A gift to Amazon’s vast online marketplace can be used to buy just about anything, and receive fast shipping to boot. Handmade gifts are the best. Especially when you eliminate all variables of actually making the gift and purchase items made by someone else’s (skilled) hands. An Etsy e-gift card feels extra nice this year, supporting local artisans and small businesses. The Wayfair e-gift card is perfect for anyone who works at home or does anything at home. Wayfair has everything for every room in every home. That’s not their slogan, but it should be. They even have outside-the-home covered, like coveted patio heaters . Give the gift of a Wayfair e-gift card and leave the (exciting and) overwhelming decision-making to your giftee. The Bay is the oldest and longest-surviving company in North America, and it’s Canadian. Let’s support our heritage by gifting a Hudson’s Bay e-gift card . The company was founded in 1670, but the company offers the latest and greatest and most fashionable products in most gifting categories. The Bay e-gift card is perfect for those who love their Scratch & Saves and/or their brand names. Oh! And the best thing of all, you can upload your own picture for a personalized e-gift card. DavidsTea is another well-loved Canadian company. DavidsTea offers great high-quality tea. The COVID-19 pandemic has been extremely tough on this retailer. The company had 240 retail stores and had to shut down all 42 American and 166 Canadian locations. The company is restructuring to focus on e-commerce, so it’s a perfect opportunity to gift a DavidsTea e-gift card , and support a Canadian company in need. KiwiCo For those who have younger humans on their gift list, KiwiCo has an extensive assortment of toys, games and gifts for kids aged 0 to 18. Subscriptions are themed to STEAM activities (science, technology, engineering, arts and math) for a world of discovery. For those who love their Kobo, a Kobo e-gift card is an easy win. Buy the gift of the convenient word. The e-book version of a book is usually less expensive and is instantly accessible. So your giftee can get a lot more e-bang for your e-buck. Does someone on your gift list love books but also maybe more so a pillow? Or a candle? Indigo e-gift cards have got you covered. Give the gift of the written word, or items that will set the perfect environment for written word consumption — or as normal people call it — reading. It’s never too late to send your loved ones some love this holiday season. Happy e-gifting! Shopping Essentials is a category written by research-obsessed shopping experts. Explore product reviews, recommendations and launches — plus behind-the-scenes info on your favourite brands and hidden gems — learn more here or sign up for our newsletter .Dublin Bay South General Election 2024 updates: James Geoghegan remains in pole position; Ivana Bacik in talks to build ‘left bloc’